AI assistant
Emami Ltd — Annual Report 2020
Jun 26, 2020
61637_rns_2020-06-26_6b175f23-de4e-409c-be52-574ec321f253.pdf
Annual Report
Open in viewerOpens in your device viewer





Q4 & FY20 Performance Update
26th June 2020
FY20 Performance Snapshot (Consolidated)

| Key Financials | FY20 Growth | Q4FY20 Growth |
9MFY20 Growth* |
|---|---|---|---|
| Consolidated Revenue Growth | -1% | -17% | 3% |
| Domestic Business Growth (incl. Institutional) |
-4% | -19% | 0% |
| International Business growth | 16% | -4% | 24% |
| EBIDTA Growth | -5% | -37% | 4% |
| PAT Growth | 0% | -58% | 13% |
| Cash Profit Growth |
2% | -21% | 8% |
*Limited Review
- Weak rural demand and liquidity concerns persisted prior to lockdown and supply chain disrupted from mid-March due to COVID-19
- Operations came to a complete halt during the last week of March due to nation wide lockdown affecting the pre-season sale of the summer portfolio impacting Q4 & FY20 performance
Business Performance


Key Market Shares

| Key Brands | Market Share Volume* |
Growth over PY |
|---|---|---|
| Navratna Oils |
66.4% | + 10 bps |
| Zandu + Mentho Plus Balms |
54.9% | + 130bps |
| BoroPlus Antiseptic Cream |
74.1% | + 30bps |
| Fair and Handsome Cream |
65.3% | - 30 bps |
| Kesh King Oil |
26.6% | + 140 bps |
Domestic Brandwise performance

| Key Brands | FY20 Growth | Q4FY20 Growth |
9MFY20 Growth |
|---|---|---|---|
| Navratna Range |
-2% | -12% | 4% |
| Pain Management Range | 3% | -5% | 5% |
| BoroPlus Range |
-7% | -77% | 0% |
| Kesh King Range |
1% | -26% | 12% |
| Healthcare Range | -2% | -9% | 1% |
| Male Grooming Range | -29% | -42% | -25% |
| 7 Oils in One | 29% | 5% | 39% |
Foray into Hygiene space


BoroPlus Advanced Anti-Germ Hand Sanitizer
Launched in April'20

BoroPlus Antiseptic+ Moisturizing Soap
Launched in June'20

BoroPlus Antiseptic+ Moisturizing Handwash
To be launched in June'20
New Launches in Healthcare Range



Zandu Ayurvedic Hand Sanitizer
Zandu Ayush Kwath Powder
Launched in June'20
An Ayurvedic immunity booster Kadha launched in June'20

Zandu Single Herb Range
- Amalaki: Guaranteed immunity builder
- Asvagandha: Immunity Booster / Adaptogenic stress buster
- Giloy: Immunity booster / promotes liver function
- Neem: Immunity booster / protects from skin infections
- Tulasi: Immunity booster for family
- Turmeric: Immunity Booster / Protects from infections
New Launches/ Relaunches in Q4FY20


Navratna Smart Cool Talc relaunched as "Maxx Cool" for Longest Lasting Cooling

Relaunched Navratna Cool Talc with modernized packaging and superior claims

Launched BoroPlus Organic Aloevera Gel - The only gel with 100% organic Aloe Leaf Extract, Antiseptic Herbs & Vitamin E for Healthy, Hydrated and Nourished Skin and Hair
New Media campaigns

8

Roped in Bollywood superstar Salman Khan as Raahat Raja, the popular icon of Navratna.
The commercial has been directed by Nitesh Tiwari (Dangal and Chhichhore fame)
Expected to extend the product messaging to the masses

Digital Campaign for Zandu Immunity Building range

Aired Medifacts Campaign to build superiority of Zandu Balms against painkiller tablets
International Business

- Sales grew by 16% in FY20. However, sales declined by 4% in Q4
- SAARC, MENAP and CIS grew in double digits in FY20
- Market shares across key markets continued to grow consistently –
- Bangladesh (Navratna, Fair and Handsome and 7 Oils in One)
- UAE (Navratna and Fair and Handsome)
- Russia (BoroPlus)

- SAARC South Asian Association for Regional Cooperation (Major countries – Bangladesh, Nepal, Sri Lanka etc.)
- SEA South East Asia (Major countries – Malaysia, Myanmar & Singapore)
- MENAP Middle East, North Africa & Pakistan (Major countries – UAE, Qatar, Oman, Kuwait, Bahrain etc.)
- CIS Commonwealth of Independent States (Major Countries – Russia, Ukraine etc.)

Financial Analysis
Earnings analysis for Q4 & FY20
Q4FY20 Financial analysis


FY20 Financial analysis


12
Q4FY20 Summarized Financials

₹ in Millions
| Particulars | Q4FY20 | % | Q4FY19 | % | Growth % |
|---|---|---|---|---|---|
| Net Sales | 5,228.3 | 98.2% | 6,350.3 | 99.2% | -17.7% |
| Other Operating Income | 98.5 | 1.8% | 53.2 | 0.8% | 85.2% |
| Revenue from Operations | 5,326.8 | 100.0% | 6,403.5 | 100.0% | -16.8% |
| Materials Cost | 1,856.0 | 34.8% | 2,507.7 | 39.2% | -26.0% |
| A&P | 989.1 | 18.6% | 989.8 | 15.5% | -0.1% |
| Staff Cost | 720.6 | 13.5% | 680.9 | 10.6% | 5.8% |
| Admn & Other Exp | 775.8 | 14.6% | 670.9 | 10.5% | 15.6% |
| EBIDTA | 985.3 | 18.5% | 1,554.2 | 24.3% | -36.6% |
| Other Income | 144.9 | 2.7% | 165.6 | 2.6% | -12.5% |
| Interest | 24.1 | 0.5% | 62.1 | 1.0% | -61.2% |
| Amortisation of acquired TM's/ brands | 633.0 | 11.9% | 650.3 | 10.2% | -2.7% |
| Depreciation/Amortisation of other assets | 219.4 | 4.1% | 159.7 | 2.5% | 37.4% |
| PBT before Exceptional Items | 253.7 | 4.8% | 847.7 | 13.2% | -70.1% |
| Exceptional Items | 74.2 | 1.4% | - | 0.0% | 100.0% |
| PBT | 179.5 | 3.4% | 847.7 | 13.2% | -78.8% |
| Tax | (73.7) | -1.4% | 279.8 | 4.4% | -126.3% |
| PAT | 253.2 | 4.8% | 567.9 | 8.9% | -55.4% |
| Share of Minority Interest & P/L of Associate | (19.6) | -0.4% | (6.4) | -0.1% | 206.2% |
| PAT After Minority Interest & Associate | 233.6 | 4.4% | 561.5 | 8.8% | -58.4% |
| Cash Profit (PAT + Dep. & Amortization) | 1,086.0 | 20.4% | 1,371.5 | 21.4% | -20.8% |
| EPS - Rs. |
0.51 | 1.24 | |||
| Cash EPS- Rs. |
2.39 | 3.02 |
FY20 Summarized Financials

₹ in Millions
| Particulars | FY20 | % | FY19 | % | Growth % |
|---|---|---|---|---|---|
| Net Sales | 26,106.4 | 98.3% | 26,589.2 | 98.7% | -1.8% |
| Other Operating Income | 442.4 | 1.7% | 357.1 | 1.3% | 23.9% |
| Revenue from Operations | 26,548.8 | 100.0% | 26,946.3 | 100.0% | -1.5% |
| Materials Cost | 8,761.0 | 33.0% | 9,230.1 | 34.3% | -5.1% |
| A&P | 4,711.4 | 17.7% | 4,701.8 | 17.4% | 0.2% |
| Staff Cost | 2,995.1 | 11.3% | 2,797.2 | 10.4% | 7.1% |
| Admn & Other Exp | 3,175.9 | 12.0% | 2,945.0 | 10.9% | 7.8% |
| EBIDTA | 6,905.4 | 26.0% | 7,272.2 | 27.0% | -5.0% |
| Other Income | 570.7 | 2.1% | 349.0 | 1.3% | 63.5% |
| Interest | 210.1 | 0.8% | 214.0 | 0.8% | -1.8% |
| Amortisation of acquired TM's/ brands | 2,589.0 | 9.8% | 2,485.0 | 9.2% | 4.2% |
| Depreciation/Amortisation of other assets | 774.3 | 2.9% | 768.2 | 2.9% | 0.8% |
| PBT before Exceptional Items | 3,902.7 | 14.7% | 4,154.0 | 15.4% | -6.0% |
| Exceptional Items | 106.8 | 0.4% | 98.0 | 0.4% | 9.0% |
| PBT | 3,795.9 | 14.3% | 4,056.0 | 15.1% | -6.4% |
| Tax | 712.7 | 2.7% | 1,008.8 | 3.7% | -29.4% |
| PAT | 3,083.2 | 11.6% | 3,047.2 | 11.3% | 1.2% |
| Share of Minority Interest & P/L of Associate | (54.1) | -0.2% | (14.9) | -0.1% | 263.1% |
| PAT After Minority Interest & Associate | 3,029.1 | 11.4% | 3,032.3 | 11.3% | -0.1% |
| Cash Profit (PAT + Dep. & Amortization) | 6,392.4 | 24.1% | 6,285.5 | 23.3% | 1.7% |
| EPS - Rs. |
6.67 | 6.68 | |||
| Cash EPS- Rs. |
14.08 | 13.85 |
Balance Sheet

₹ in Millions
| Sl. | ASSETS | As at 31.03.2020 |
As at 31.03.2019 |
Sl. | EQUITY AND LIABILITIES | As at 31.03.2020 |
As at 31.03.2019 |
|---|---|---|---|---|---|---|---|
| 1 | Non -Current Assets | Equity | |||||
| (a) | Property, Plant and Equipment | 7,685 | 7,490 | (a) | Equity Share capital | 453 | 454 |
| (b) | Capital work-in-progress | 69 | 352 | (b) | Other Equity | 17,784 | 20,307 |
| (c) | Investment Property | 545 | 548 | Total Equity attributable to owners of the Parent | 18,238 | 20,761 | |
| (d) | Goodwill | - | 41 | (c) | Non-Controlling Interest | (9) | (2) |
| (e) | Other Intangible Assets | 6,191 | 8,722 | Total Equity | 18,229 | 20,759 | |
| (f) | Right of Use Assets | 172 | - | ||||
| (g) | Intangible assets under development | 12 | 11 | ||||
| (h) | Financial Assets | ||||||
| (i) Investments | LIABILITIES | ||||||
| a) Investment in Associates | 212 | 160 | 1 | Non-Current Liabilities | |||
| b) Others | 669 | 1,631 | (a) | Financial Liabilities | |||
| (ii) Loans | 117 | 143 | (i) Other Financial Liabilities | 154 | 69 | ||
| (iii) Other Financial Assets | 394 | 291 | |||||
| (i) | Deferred Tax Assets (net) | 0 | 38 | ||||
| (j) | Non-Current Tax Assets | 135 | 126 | (b) | Provisions | 231 | 200 |
| (k) | Other Non-Current Assets | 253 | 178 | (c) | Deferred tax liabilities (Net) | 35 | 160 |
| (d) | Other Non-Current Liabilities | 216 | 237 | ||||
| 16,452 | 19,730 | 636 | 666 | ||||
| 2 | Current assets | ||||||
| (a) | Inventories | 2,447 | 2,217 | 2 | Current liabilities | ||
| (b) | Financial Assets | (a) | Financial Liabilities | ||||
| (i) Investments | 683 | 79 | (i) Borrowings | 2,102 | 1,099 | ||
| (ii) Trade Receivables | 3,080 | 2,164 | (ii) Trade Payables | ||||
| Total oustanding dues of Micro & Small | |||||||
| (iii) Cash & Cash Equivalents | 108 | 1,165 | enterprise | 230 | 30 | ||
| Total oustanding dues of creditors others than | |||||||
| (iv) Bank Balances other than (iii) above | 1,082 | 869 | Micro & Small Enterprises | 3,014 | 2,883 | ||
| (v) Loans | 663 | 29 | (iii) Other Financial Liabilities | 520 | 1,326 | ||
| (vi) Other Financial Assets | 785 | 498 | (b) | Other Current Liabilities | 486 | 245 | |
| (c) | Provisions | 1,455 | 1,153 | ||||
| (c) | Other Current Assets | 1,484 10,333 |
1,473 8,493 |
(d) | Current Tax Liabilities (Net) | 112 7,920 |
63 6,800 |
| Total Assets | 26,785 | 28,224 | Total Equity and Liabilities | 26,785 | 28,224 |
Awards & Accolades
- Awarded the "Company of the year– FMCG" by CNBC-Awaaz for the company's outstanding performance on parameters such as growth, capital efficiency and profitability over a period of time
- Zandu Balm, BoroPlus and Navartna bagged 35th, 75th and 96th positions among the " Top 100 Most Trusted Brands" under the aegis of The Economic Times - Brand Equity
- HE Magic Duo and Emami 7 Oils in One were conferred with the 'Recognition of Product Packaging" under the Innovation, Creativity and Development Category. Also received the "President's Special Award" for the new and fresh packaging concept of Emami 7 Oils in One out of the Top 3 Shortlisted Packaging among all entries from SIES Educational group.


